Re. Re.: "Immunothrombotic dysregulation in Chagas disease and COVID19: a comparative study of anticoagulation"

Mol Cell Biochem. 2023 Feb;478(2):361-362. doi: 10.1007/s11010-022-04511-3. Epub 2022 Jul 13.

Abstract

Re. Re.: "Immunothrombotic dysregulation in Chagas disease (CD) and COVID-19: a comparative study of anticoagulation": In the commentary on our paper, Hasslocher-Moreno made the point that indeterminate and digestive forms are not related to thromboembolic events, only thrombogenic alterations occur in CD with cardiopathy, however there is indirect evidence related to thombotic alterations, such as cerebral thrombosis. Our assertion is based on previous data discussed in this letter.

Keywords: COVID-19; Chagas disease; Thrombosis.

Publication types

  • Review

MeSH terms

  • Anticoagulants / pharmacology
  • Anticoagulants / therapeutic use
  • COVID-19*
  • Chagas Disease* / drug therapy
  • Humans

Substances

  • Anticoagulants